Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
California pharmacy committee sends proposed CCR §1711 changes on quality‑assurance programs to full board
Summary
The Enforcement and Compounding Committee voted April 16 to refer proposed amendments to CCR §1711 — which emphasize aggregate medication‑error analysis and align the definition of 'medication error' with BPC 4113.1 — to the full California State Board of Pharmacy for rulemaking and further discussion.
The California State Board of Pharmacy Enforcement and Compounding Committee on April 16 agreed to refer proposed amendments to Title 16, California Code of Regulations section 1711 — updating quality‑assurance (QA) program requirements for pharmacies — to the full board for consideration and possible rulemaking.
Chair Maria Serpa said staff reorganized and clarified the regulation text, adding requirements that pharmacies adopt policies and procedures defining medication‑error review, notifications to impacted parties, the frequency of aggregate medication‑error reports, and how the pharmacist in charge (PIC) must review both individual and aggregate reports. "I appreciate how staff have reorganized and clarified the information in 1711. The result is a more clear regulation," Serpa said.
Board members broadly…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
